✉news TechnologyAI first seen 3 d ago, last 3 d ago, peak #2
AI Is Expanding Drug Pipelines, But Quality Concerns Grow
Original: AI Is Making Drug Pipelines Bigger. It Might Also Be Making Them Worse.
A new analysis argues that artificial intelligence is swelling pharmaceutical pipelines with more drug candidates, but questions whether the added volume is improving overall quality. Observers in the biotech and pharma world are debating whether AI-generated discovery is flooding development with weaker assets that could raise failure rates downstream rather than delivering better medicines faster.
Why now: Ongoing debate about whether AI-driven drug discovery genuinely improves R&D output or just inflates it
pharmaceutical industryartificial intelligencedrug development
Rank over time, top of the chart is #1. 3 snapshots from 3 d ago to 3 d ago.
Evidence
- AI Is Making Drug Pipelines Bigger. It Might Also Be Making Them Worse. · The Clinical Trial Vanguard
API: https://socialmediatrends-api.osmike.com/v1/trends/4750793